Nomura Holdings Inc. Lowers Position in Medtronic PLC $MDT

Nomura Holdings Inc. cut its position in shares of Medtronic PLC (NYSE:MDT) by 70.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,793 shares of the medical technology company’s stock after selling 104,315 shares during the quarter. Nomura Holdings Inc.’s holdings in Medtronic were worth $3,817,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. 1248 Management LLC purchased a new position in Medtronic during the 1st quarter valued at about $26,000. Twin Tree Management LP bought a new position in shares of Medtronic during the first quarter valued at approximately $29,000. Activest Wealth Management lifted its holdings in shares of Medtronic by 3,577.8% during the first quarter. Activest Wealth Management now owns 331 shares of the medical technology company’s stock valued at $30,000 after purchasing an additional 322 shares during the last quarter. GFG Capital LLC bought a new stake in shares of Medtronic in the 2nd quarter worth approximately $36,000. Finally, True Wealth Design LLC grew its stake in shares of Medtronic by 49.8% in the 2nd quarter. True Wealth Design LLC now owns 421 shares of the medical technology company’s stock worth $37,000 after buying an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

MDT has been the subject of a number of recent research reports. Jefferies Financial Group reiterated a “hold” rating and set a $110.00 price objective on shares of Medtronic in a research note on Wednesday, November 19th. Sanford C. Bernstein set a $111.00 price target on Medtronic in a research report on Wednesday, November 19th. UBS Group upped their price target on shares of Medtronic from $95.00 to $102.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 19th. Barclays raised their price objective on shares of Medtronic from $109.00 to $111.00 and gave the company an “overweight” rating in a research note on Thursday, November 20th. Finally, Argus upped their target price on shares of Medtronic from $105.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat.com, Medtronic currently has a consensus rating of “Moderate Buy” and an average target price of $110.44.

Medtronic Price Performance

Shares of NYSE:MDT opened at $98.68 on Tuesday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.80 and a current ratio of 2.42. The firm has a market cap of $126.51 billion, a price-to-earnings ratio of 26.60, a price-to-earnings-growth ratio of 2.63 and a beta of 0.71. The business has a 50-day simple moving average of $97.28 and a two-hundred day simple moving average of $93.07. Medtronic PLC has a fifty-two week low of $79.29 and a fifty-two week high of $106.33.

Medtronic (NYSE:MDT) last announced its quarterly earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The firm had revenue of $8.96 billion during the quarter, compared to analyst estimates of $8.86 billion. During the same period in the previous year, the business posted $1.26 earnings per share. The business’s revenue for the quarter was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, analysts expect that Medtronic PLC will post 5.46 earnings per share for the current year.

Medtronic Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 16th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic’s dividend payout ratio is presently 76.55%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.